Corvus Pharmaceuticals Inc sell StockNews.com
Start price
03.04.23
/
50%
€0.92
Target price
03.04.24
-
Performance (%)
81.96%
End price
04.04.24
€1.67
Summary
This prediction ended on 04.04.24 with a price of €1.67. The price for Corvus Pharmaceuticals Inc massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Corvus Pharmaceuticals Inc | 8.288% | 8.288% | 108.639% |
iShares Core DAX® | -1.215% | 4.788% | 16.604% |
iShares Nasdaq 100 | -1.911% | 1.109% | 19.364% |
iShares Nikkei 225® | -3.171% | 5.626% | 10.519% |
iShares S&P 500 | -1.029% | 1.792% | 20.514% |
Comments by StockNews_com for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.65
26.03.23
26.03.23
-
26.03.24
26.03.24
144.58%
27.03.24
27.03.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.68
18.03.23
18.03.23
-
18.03.24
18.03.24
157.58%
19.03.24
19.03.24